1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Analysis of the Ethiopian Pharmaceutical Market 

Analysis of the Ethiopian Pharmaceutical Market 

  • January 2016
  • -
  • Frost & Sullivan
  • -
  • 77 pages

Analysis of the Ethiopian Pharmaceutical Market : Market Position of Prescription and Over-the-counter Drugs

This study offers an insight into the pharmaceutical industry of Ethiopia, where preference for generic, prescription drugs is growing. There is information on recent reforms introduced by the government (like tax benefits for in-country production, national strategy, and plan of action for pharmaceutical manufacturing development, growth and transformation plan, and so on), key participants in the market, population and disease statistics, and so on. The study also describes the opportunities and constraints in the market and revenue forecasts for the total market from 2011–2020. Primary research interviews with industry stakeholders and secondary research through in-house Frost & Sullivan database and news reports were undertaken.

Key Findings

The Government of Ethiopia is encouraging the growth of the healthcare and pharmaceutical industry through a number of initiatives.

-The First Growth and Transformation Plan (GTP-I) has successfully enhanced the healthcare environment with increased facilities, better access to services, and improvement in health indicators.

-Owing to the success of GTP-I, GTP-II is being implemented to further increase the access of health services across the nation.

-There is an evident growth in the share of generic medication, with increased production by manufacturing plants in Ethiopia and supply from foreign manufacturers. This increase in share has resulted from high demand (owing to the escalating population and increase in incidences of noncommunicable diseases), as well as the low cost of generic medicines that works in the favour of this price-oriented market.

-The government has also collaborated with the World Health Organization (WHO) and launched the National Strategy and Plan of Action for Pharmaceutical Manufacturing Development in Ethiopia. This plan is expected to increase pharmaceutical production in the country, improve medicine quality, and strengthen the national medicine regulatory system.

-There is a plethora of Ethiopian and non-Ethiopian pharmaceutical companies offering generic and branded medication. Local manufacturers have approximately % market share but their share is expected to increase with the implementation of upcoming reforms in the industry,

-The government offers tax incentives (income tax exemptions and tax-free loans) to those manufacturers who intend to set up or revamp existing production facilities in the country.

-Between 2014 and 2020, the pharmaceutical industry of Ethiopia is expected to grow at a CAGR of approximately % and reach market size of approximately $ billion by 2020.

Table Of Contents

Analysis of the Ethiopian Pharmaceutical Market 
1 EXECUTIVE SUMMARY

Executive Summary
1. Key Findings
2. Scope and Segmentation
3. Key Questions this Study will Answer
4. Measurements
5. CEO's Perspective
6. Key Companies to Watch
7. Executive Summary—3 Big Predictions

2 MARKET OVERVIEW

Market Overview
1. About Ethiopia
2. Infrastructure and Economic Situation
3. Healthcare Industry
4. Healthcare Infrastructure
5. Disease Profile
6. Healthcare Financing Indicators
7. Pharmaceutical Market—Background
8. Process of Procurement and Distribution
9. Essential Requirements for Drug Registration
10. Total Pharmaceutical Market—Segmentation
11. Increase in Generic Drugs' Market Share
12. Total Pharmaceutical Market—Segmentation
13. Federation of East African Pharmaceutical Manufacturers

3 COMPETITIVE PLAYBOOK

Competitive Playbook
1. New Market Opportunities
2. New Market Opportunities (continued)
3. Merger, Acquisition, and Partnership Assessment

4 DRIVERS, RESTRAINTS, AND TRENDS—TOTAL PHARMACEUTICAL MARKET

Drivers, Restraints, and Trends—Total Pharmaceutical Market
1. Market Drivers
2. Market Drivers (continued)
3. Market Restraints

5 FORECAST AND TRENDS—TOTAL PHARMACEUTICAL MARKET

Forecast and Trends—Total Pharmaceutical Market
1. Measurements
2. Forecast Assumptions and Definitions
3. Revenue Forecast by Market Size
4. Per Cent Revenue Forecast by Nonprescription, Generic, and Branded Drugs
5. Revenue Forecast Discussion
6. Growth Analysis of Key Therapeutic Segments
7. Growth Forecast of Key Therapeutic Segments
8. Total Pharmaceutical Market—PESTLE Analysis

6 COMPETITIVE ENVIRONMENT

Competitive Environment
1. Market Share—Prescription Drugs and Nonprescription Drugs
2. Market Share—Generic Drugs
3. Market Share—Branded Drugs

7 KEY COMPANIES TO WATCH

Key Companies to Watch
1. Companies to Watch
2. Companies to Watch (continued)
3. Addis Pharmaceutical Factory PLC
4. Aurobindo Pharma Limited
5. Cadila Pharmaceutical Limited
6. GlaxoSmithKline PLC
7. Julphar (Gulf Pharmaceutical Industries)
8. Novartis International AG

8 THE LAST WORD

The Last Word
1. The Last Word—3 Big Predictions
2. The Last Word—Discussion
3. The Last Word—Discussion (continued)
4. The Last Word—Discussion (continued)
5. Legal Disclaimer

9 APPENDIX

Appendix
1. Drivers Explained
2. Drivers Explained (continued)
3. Drivers Explained (continued)
4. Drivers Explained (continued)
5. Drivers Explained (continued)
6. Restraints Explained
7. Restraints Explained (continued)
8. Restraints Explained (continued)
9. List of Companies in “Others”
10. List of Companies in “Others”
11. Methodology
12. Learn More—Next Steps
13. List of Exhibits
14. List of Exhibits (continued)
15. List of Exhibits (continued)

List of Exhibits


Total Pharmaceutical Market: Market Engineering Measurements, Ethiopia, 2014
Population Split by Gender, Ethiopia, 2014
Inflation at Consumer Prices, Ethiopia, 2010-2014
Annual Infrastructural Improvements, Ethiopia, 2011-2015
Healthcare Statistics, Ethiopia, 2011 and 2013
Structure of Public Healthcare in Ethiopia
Per cent of Health Facilities, Ethiopia, 2012
Total Number of Hospitals by Region, Ethiopia, 2012
Top Causes of Deaths, Ethiopia, 2012
Disease Indicators, Ethiopia, 2011 and 2013
Healthcare Expenditures, Ethiopia, 2010-2013
Per cent of Imported Drugs Versus Locally Manufactured Drugs, Ethiopia. 2014
Total Pharmaceutical Market: Procurement Process, Ethiopia, 2014
Total Pharmaceutical Market: Market Segmentation, Ethiopia, 2014
Total Pharmaceutical Market: Per cent Sales Breakdown by Therapeutic Segment, Ethiopia, 2014
Members of the Ethiopian Pharmaceuticals and Medical Supplies Manufacturing Industries Association
Total Pharmaceutical Market: Game-changing Strategies, Ethiopia, 2014
Total Pharmaceutical Market: Market Outlook, Ethiopia, 2011-2014
Total Pharmaceutical Market: Key Market Drivers, Ethiopia, 2015-2020
Total Pharmaceutical Market: Key Market Restraints, Ethiopia, 2015-2020
Total Pharmaceutical Market: Market Engineering Measurements, Ethiopia, 2014
Total Pharmaceutical Market: Revenue Forecast, Ethiopia, 2011-2020
Total Pharmaceutical Market: Per cent Revenue Forecast by Nonprescription, Generic and Branded Drugs, Ethiopia, 2011-2020
Total Pharmaceutical Market: Therapeutic Segment Growth Analysis, Ethiopia, 2015-2020
Total Pharmaceutical Market: Growth Forecast by Therapeutic Segments, Ethiopia, 2014
Total Pharmaceutical Market: PESTLE Analysis, Ethiopia, 2014
Total Pharmaceutical Market: Per Cent Revenue Breakdown, Ethiopia, 2014
Generic Drugs Segment: Per Cent Revenue Breakdown, Ethiopia, 2014
Branded Drugs Segment: Per Cent Revenue Breakdown, Ethiopia, 2014
GDP Per Capita, Ethiopia, 2010-2014
Health Financing Sources, Ethiopia, 2013
Historical and Projected Population, Ethiopia, 2009-2020

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.